Loading…

Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels

A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroscience research 2016-02, Vol.94 (2), p.179-189
Main Authors: Verleye, Marc, Buttigieg, Dorothée, Steinschneider, Rémy
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3
cites cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3
container_end_page 189
container_issue 2
container_start_page 179
container_title Journal of neuroscience research
container_volume 94
creator Verleye, Marc
Buttigieg, Dorothée
Steinschneider, Rémy
description A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 > 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc. Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.
doi_str_mv 10.1002/jnr.23688
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780516910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3895687641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</originalsourceid><addsrcrecordid>eNp1kU9v1DAQxS1ERZfCgS-AInGBQ1qP7djxkS60tKqWCoF6tJxkQr3kz2I7W_bb47BtD5U4zYz9myf7PULeAD0GStnJevDHjMuyfEYWQLXKRSHUc7KgXNJcUGCH5GUIa0qp1gV_QQ6ZLAAELxckrnDy48aPEevotpjZubi4y8Y2C9F5t8Ehjl125-JtZrPNGIKrOszcsB27LfbpdkbTEO1PzBtMfDMf1rar3dRndmiyMDZzW9_aYcAuvCIHre0Cvr6vR-TH2efvyy_51dfzi-XHq7wWWpR5baFpFcpKsaYVimvLisoWWnJoJQOhASoUYBUIEFVVgmAcWGsrqgVrFPIj8n6vm_73e8IQTe9CjV1nBxynYECVtACpgSb03RN0PU5-SK9LlNBUAmNloj7sqdonHzy2ZuNdb_3OADVzFCZFYf5Fkdi394pT1WPzSD54n4CTPXDnOtz9X8lcrr49SOb7DRci_nncsP6XkYqrwtyszs1SipvT60_X5oz_BQ3go1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749061228</pqid></control><display><type>article</type><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><source>Wiley</source><creator>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</creator><creatorcontrib>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</creatorcontrib><description>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 &gt; 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc. Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.23688</identifier><identifier>PMID: 26511438</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics ; Animals ; Brain-Derived Neurotrophic Factor - pharmacology ; Calcium - metabolism ; Cells, Cultured ; Cerebral Cortex - cytology ; Dioxolanes - pharmacology ; Embryo, Mammalian ; Fibrinolytic Agents - pharmacokinetics ; Glucose - deficiency ; Glutamic Acid - pharmacology ; Hippocampus - cytology ; Hirudins - pharmacokinetics ; L-glutamate ; Mice, Inbred C57BL ; Neurofilament Proteins - metabolism ; Neuroglia - drug effects ; neuronal-astroglial culture ; Neurons - drug effects ; neuroprotection ; Neuroprotective Agents - pharmacology ; oxygen-glucose deprivation ; Protein Binding - drug effects ; Rats ; Receptors, Glutamate - metabolism ; Recombinant Proteins - pharmacokinetics ; Sodium - metabolism ; stiripentol ; Tritium - pharmacokinetics ; voltage-gated sodium and calcium channels</subject><ispartof>Journal of neuroscience research, 2016-02, Vol.94 (2), p.179-189</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>2016 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</citedby><cites>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26511438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verleye, Marc</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Steinschneider, Rémy</creatorcontrib><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><title>Journal of neuroscience research</title><addtitle>Journal of Neuroscience Research</addtitle><description>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 &gt; 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc. Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</description><subject>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics</subject><subject>Animals</subject><subject>Brain-Derived Neurotrophic Factor - pharmacology</subject><subject>Calcium - metabolism</subject><subject>Cells, Cultured</subject><subject>Cerebral Cortex - cytology</subject><subject>Dioxolanes - pharmacology</subject><subject>Embryo, Mammalian</subject><subject>Fibrinolytic Agents - pharmacokinetics</subject><subject>Glucose - deficiency</subject><subject>Glutamic Acid - pharmacology</subject><subject>Hippocampus - cytology</subject><subject>Hirudins - pharmacokinetics</subject><subject>L-glutamate</subject><subject>Mice, Inbred C57BL</subject><subject>Neurofilament Proteins - metabolism</subject><subject>Neuroglia - drug effects</subject><subject>neuronal-astroglial culture</subject><subject>Neurons - drug effects</subject><subject>neuroprotection</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>oxygen-glucose deprivation</subject><subject>Protein Binding - drug effects</subject><subject>Rats</subject><subject>Receptors, Glutamate - metabolism</subject><subject>Recombinant Proteins - pharmacokinetics</subject><subject>Sodium - metabolism</subject><subject>stiripentol</subject><subject>Tritium - pharmacokinetics</subject><subject>voltage-gated sodium and calcium channels</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kU9v1DAQxS1ERZfCgS-AInGBQ1qP7djxkS60tKqWCoF6tJxkQr3kz2I7W_bb47BtD5U4zYz9myf7PULeAD0GStnJevDHjMuyfEYWQLXKRSHUc7KgXNJcUGCH5GUIa0qp1gV_QQ6ZLAAELxckrnDy48aPEevotpjZubi4y8Y2C9F5t8Ehjl125-JtZrPNGIKrOszcsB27LfbpdkbTEO1PzBtMfDMf1rar3dRndmiyMDZzW9_aYcAuvCIHre0Cvr6vR-TH2efvyy_51dfzi-XHq7wWWpR5baFpFcpKsaYVimvLisoWWnJoJQOhASoUYBUIEFVVgmAcWGsrqgVrFPIj8n6vm_73e8IQTe9CjV1nBxynYECVtACpgSb03RN0PU5-SK9LlNBUAmNloj7sqdonHzy2ZuNdb_3OADVzFCZFYf5Fkdi394pT1WPzSD54n4CTPXDnOtz9X8lcrr49SOb7DRci_nncsP6XkYqrwtyszs1SipvT60_X5oz_BQ3go1A</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Verleye, Marc</creator><creator>Buttigieg, Dorothée</creator><creator>Steinschneider, Rémy</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>201602</creationdate><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><author>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics</topic><topic>Animals</topic><topic>Brain-Derived Neurotrophic Factor - pharmacology</topic><topic>Calcium - metabolism</topic><topic>Cells, Cultured</topic><topic>Cerebral Cortex - cytology</topic><topic>Dioxolanes - pharmacology</topic><topic>Embryo, Mammalian</topic><topic>Fibrinolytic Agents - pharmacokinetics</topic><topic>Glucose - deficiency</topic><topic>Glutamic Acid - pharmacology</topic><topic>Hippocampus - cytology</topic><topic>Hirudins - pharmacokinetics</topic><topic>L-glutamate</topic><topic>Mice, Inbred C57BL</topic><topic>Neurofilament Proteins - metabolism</topic><topic>Neuroglia - drug effects</topic><topic>neuronal-astroglial culture</topic><topic>Neurons - drug effects</topic><topic>neuroprotection</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>oxygen-glucose deprivation</topic><topic>Protein Binding - drug effects</topic><topic>Rats</topic><topic>Receptors, Glutamate - metabolism</topic><topic>Recombinant Proteins - pharmacokinetics</topic><topic>Sodium - metabolism</topic><topic>stiripentol</topic><topic>Tritium - pharmacokinetics</topic><topic>voltage-gated sodium and calcium channels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verleye, Marc</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Steinschneider, Rémy</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verleye, Marc</au><au>Buttigieg, Dorothée</au><au>Steinschneider, Rémy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>Journal of Neuroscience Research</addtitle><date>2016-02</date><risdate>2016</risdate><volume>94</volume><issue>2</issue><spage>179</spage><epage>189</epage><pages>179-189</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 &gt; 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc. Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26511438</pmid><doi>10.1002/jnr.23688</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 2016-02, Vol.94 (2), p.179-189
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_1780516910
source Wiley
subjects alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics
Animals
Brain-Derived Neurotrophic Factor - pharmacology
Calcium - metabolism
Cells, Cultured
Cerebral Cortex - cytology
Dioxolanes - pharmacology
Embryo, Mammalian
Fibrinolytic Agents - pharmacokinetics
Glucose - deficiency
Glutamic Acid - pharmacology
Hippocampus - cytology
Hirudins - pharmacokinetics
L-glutamate
Mice, Inbred C57BL
Neurofilament Proteins - metabolism
Neuroglia - drug effects
neuronal-astroglial culture
Neurons - drug effects
neuroprotection
Neuroprotective Agents - pharmacology
oxygen-glucose deprivation
Protein Binding - drug effects
Rats
Receptors, Glutamate - metabolism
Recombinant Proteins - pharmacokinetics
Sodium - metabolism
stiripentol
Tritium - pharmacokinetics
voltage-gated sodium and calcium channels
title Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20activity%20of%20stiripentol%20with%20a%20possible%20involvement%20of%20voltage-dependent%20calcium%20and%20sodium%20channels&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Verleye,%20Marc&rft.date=2016-02&rft.volume=94&rft.issue=2&rft.spage=179&rft.epage=189&rft.pages=179-189&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.23688&rft_dat=%3Cproquest_cross%3E3895687641%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1749061228&rft_id=info:pmid/26511438&rfr_iscdi=true